Presenter Disclosure Information. I have no financial relationships to disclose:

Similar documents
Sandra Weintraub, Ph.D. Cognitive Neurology and Alzheimer s Disease Center Northwestern University, Feinberg School of Medicine Chicago, Illinois

Research on Primary Progressive Aphasia: What It Is Teaching Us About Brain Function and Progression

Do not copy or distribute without permission. S. Weintraub, CNADC, NUFSM, 2009

Form D1: Clinician Diagnosis

I do not have any disclosures

FTD basics! Etienne de Villers-Sidani, MD!

FRONTOTEMPORAL DEGENERATION: OVERVIEW, TRENDS AND DEVELOPMENTS

Brain Advance Access published February 25, doi: /brain/awu024 Brain 2014: Page 1 of 17 1

Perspectives on Frontotemporal Dementia and Primary Progressive Aphasia

Frontotemporal Dementia: Towards better diagnosis. Frontotemporal Dementia. John Hodges, NeuRA & University of New South Wales, Sydney.

Dementia Update. Daniel Drubach, M.D. Division of Behavioral Neurology Department of Neurology Mayo Clinic Rochester, Minnesota

Objectives. Objectives continued: 3/24/2012. Copyright Do not distribute or replicate without permission 1

DISCLOSURES. Objectives. THE EPIDEMIC of 21 st Century. Clinical Assessment of Cognition: New & Emerging Tools for Diagnosing Dementia NONE TO REPORT

Dementia Past, Present and Future

Dementia Update. October 1, 2013 Dylan Wint, M.D. Cleveland Clinic Lou Ruvo Center for Brain Health Las Vegas, Nevada

Non Alzheimer Dementias

The frontotemporal dementia spectrum what the general physician needs to know Dr Jonathan Rohrer

DEMENTIA 101: WHAT IS HAPPENING IN THE BRAIN? Philip L. Rambo, PhD

Biomarkers: Translating Research into Clinical Practice

LANGUAGE AND PATHOLOGY IN FRONTOTEMPORAL DEGENERATION

Dementia and Aphasia-AD, FTD & aphasia

The ABCs of Dementia Diagnosis

Sandra Weintraub, PhD Clinical Core Leader and Professor

Alzheimer s disease dementia: a neuropsychological approach

2016 Programs & Information

Version 3.0, March 2015

Clinical Diagnosis. Step 1: Dementia or not? Diagnostic criteria for dementia (DSM-IV)

Neuropsychological Evaluation of

CNADC. S. Weintraub, CNADC, Northwestern FSM, 2011 DO NOT COPY OR DISTRIBUTE WITHOUT AUTHORʼS PERMISSION

What if it s not Alzheimer s? Update on Lewy body dementia and frontotemporal dementia

The Person: Dementia Basics

M. Marsel Mesulam. Cognitive Neurology and Alzheimer s Disease Center, Northwestern University Feinberg School of Medicine Chicago, IL, USA

Prof Tim Anderson. Neurologist University of Otago Christchurch

Aging often includes changes to vision, hearing, taste, smell, skin, hair, weight & changes to Brain:

What APS Workers Need to Know about Frontotemporal, Lewy Body and Vascular Dementias

FTD/PPA Caregiver Education Conference March 11, 2011

Form A3: Subject Family History

Dementia. Assessing Brain Damage. Mental Status Examination

Define functional MRI. Briefly describe fmri image acquisition. Discuss relative functional neuroanatomy. Review clinical applications.

Common Forms of Dementia Handout Package

Development of methodology for conducting clinical trials in frontotemporal lobar degeneration

LANGUAGE IN INDIA Strength for Today and Bright Hope for Tomorrow Volume 8 : 2 February 2008

DEMENTIA Dementia is NOT a normal part of aging Symptoms of dementia can be caused by different diseases Some symptoms of dementia may include:

Imaging of Alzheimer s Disease: State of the Art

UDS version 3 Summary of major changes to UDS form packets

What is. frontotemporal. address? dementia?

Caring Sheet #11: Alzheimer s Disease:

Brain-based disorders in children, teens, and young adults: When to know there is a problem and what to do

School of Animal Biology. Jade Cartwright

shows syntax in his language. has a large neocortex, which explains his language abilities. shows remarkable cognitive abilities. all of the above.

ASHA Comments* (ASHA Recommendations Compared to DSM-5 Criteria) Austism Spectrum Disorder (ASD)

DEMENTIA? 45 Million. What is. WHAT IS DEMENTIA Dementia is a disturbance in a group of mental processes including: 70% Dementia is not a disease

NEUROGENIC COMMUNICATIVE DISORDERS KAREN RIEDEL, PH.D. CCC-SLP CLINICAL ASSOCIATE PROFESSOR RUSK REHABILITATION SCHOOL OF MEDICINE, NYULMC

Dementia and Alzheimer s disease

Diagnosis before NIA AA The impact of FDG PET in. Diagnosis after NIA AA Neuropathology and PET image 2015/10/16

Seniors Helping Seniors September 7 & 12, 2016 Amy Abrams, MSW/MPH Education & Outreach Manager Alzheimer s San Diego

Frontotemporal dementia:

Psychological Tests that Examine Brain Functioning

Mild Cognitive Impairment (MCI)

Clinicopathologic and genetic aspects of hippocampal sclerosis. Dennis W. Dickson, MD Mayo Clinic, Jacksonville, Florida USA

Primary progressive aphasia A tale of two syndromes and the rest

Brain Advance Access published July 2, doi: /brain/awt163 Brain 2013: Page 1 of 10 1

Language After Traumatic Brain Injury

Cognition and Anatomy in Three Variants of Primary Progressive Aphasia

White matter hyperintensities correlate with neuropsychiatric manifestations of Alzheimer s disease and frontotemporal lobar degeneration

SECTION 1: as each other, or as me. THE BRAIN AND DEMENTIA. C. Boden *

Department of Neurology, Kangwon National University Hospital, Chuncheon, Korea

What is frontotemporal dementia?

doi: /brain/awt266 Brain 2013: 136;

Changes, Challenges and Solutions: Overcoming Cognitive Deficits after TBI Sarah West, Ph.D. Hollee Stamper, LCSW, CBIS

Comments to this discussion are invited on the Alzforum Webinar page. Who Should Use the New Diagnostic Guidelines? The Debate Continues

What is dementia? What is dementia?

DISCLAIMER: ECHO Nevada emphasizes patient privacy and asks participants to not share ANY Protected Health Information during ECHO clinics.

Brain & Language 127 (2013) Contents lists available at SciVerse ScienceDirect. Brain & Language

CHAPTER 5 NEUROPSYCHOLOGICAL PROFILE OF ALZHEIMER S DISEASE

Decision making cognition in primary progressive aphasia

3/7/2017. Alzheimer s and Dementia Research: An Advanced Discussion. Alzheimer s and Dementia Research: An Advanced Discussion

Pamela S. Klonoff, PhD Clinical Director Center for Transitional Neuro-Rehabilitation Barrow Neurological Institute, Phoenix, Arizona

Role of TDP-43 in Non-Alzheimer s and Alzheimer s Neurodegenerative Diseases

WHAT IS DEMENTIA? An acquired syndrome of decline in memory and other cognitive functions sufficient to affect daily life in an alert patient

Dementia. Aetiology, pathophysiology and the role of neuropsychological testing. Dr Sheng Ling Low Geriatrician

Why does language set up shop where it does?

Psy /16 Human Communication. By Joseline

Navigating The Cognitive Internet: Introduction. Wendy Lemere DNP, GNP-BC Gerontological Nurse Practitioner Henry Ford Health System

What is dementia? What is dementia?

8/24/18. Dementia. Risk of Dementia Following Traumatic Brain Injury: A Review of the Literature. Media Presence. Media Presence

! slow, progressive, permanent loss of neurologic function.

doi: /brain/awr216 Brain 2011: 134;

Frontal Behavioural Inventory (FBI)

21/05/2018. Today s webinar will answer. Presented by: Valorie O Keefe Consultant Psychologist

Diagnosing Dementia: Signs & symptoms, differential diagnosis of common dementias, and non-degenerative memory loss

HHS Public Access Author manuscript JAMA Neurol. Author manuscript; available in PMC 2018 April 30.

Critical Review: The Effectiveness of Constraint-Induced Language Therapy in a Distributive Format

Why does language set up shop where it does?

Critical Review: The Efficacy of Animal-Assisted Therapy for Improving Communication Skills in Adults with Aphasia or Apraxia

Clinical phenotypes in autopsy-confirmed Pick disease

7/3/2013 ABNORMAL PSYCHOLOGY SEVENTH EDITION CHAPTER FOURTEEN CHAPTER OUTLINE. Dementia, Delirium, and Amnestic Disorders. Oltmanns and Emery

WEBINAR SERIES: AGING IN INDIVIDUALS WITH INTELLECTUAL AND DEVELOPMENTAL DISABILITIES

Effects of Response Elaboration Training on Increased Length and Complexity of Utterances with Two Participants with Fluent Aphasia

Cognitive Neuroscience of Memory

Transcription:

Sandra Weintraub, Ph.D. Cognitive Neurology and Alzheimer s Disease Center Northwestern University, Feinberg School of Medicine Chicago, Illinois http://www.brain.northwestern.edu/dementia/ppa/index.html Presenter Disclosure Information I have no financial relationships to disclose: Employee of: Northwestern University Consultant for: None Stockholder in: None Research support from: NIA.NIDCD, NINDS Honoraria from: None

PART 1: What is PPA? PPA is a clinical dementia syndrome caused by neurodegenerative disease. PART 2: How is PPA diagnosed? What are the subtypes of PPA? What tests are used to identify the aphasia profile? PART 3: What are the educational and treatment needs of patients with PPA and their caregivers? What role does the SLP play? What is the Northwestern PPA Program? PART 1: What is PPA? PPA is a clinical dementia syndrome caused by neurodegenerative disease. PART 2: How is PPA diagnosed? What are the subtypes of PPA? What tests are used to identify the aphasia profile? PART 3: What are the educational and treatment needs of patients with PPA and their caregivers? What role does the SLP play? What is the Northwestern PPA Program?

WHAT CAUSES CLINICAL DEMENTIA? ACUTE ONSET GRADUAL ONSET, PROGRESSION Metabolic Vascular Toxic Infectious Epileptic Paraneoplastic Tumor Hydrocephalus Vascular NEURODEGENERATIVE Diffuse Lewy Body Non Alzheimer FTLD Prion Other Alzheimer Disease Tauopathies TDP-43proteinopathy FUS

TYPES OF NEUROPATHOLOGY DIAGNOSED AT BRAIN AUTOPSY THAT CAUSE CLINICAL DEMENTIA SYNDROMES Frontotemporal Lobar Degeneration With TDP-43 Proteinopathy Frontotemporal Lobar Degeneration With Tau Inclusions - e.g. Pick s disease Frontotemporal Lobar Degeneration With FUS Inclusions Plaques and Tangles- Alzheimer s Disease NORMAL BRAIN TISSUE Cortical Lewy Body Disease Courtesy Eileen Bigio MD NORTHWESTERN

ACUTE EVENT Neuronatomically Focal Determined by VASCULATURE FOCAL COGNITIVE DEFICIT (e.g.,aphasia) PRE 1980 LACK OF KNOWLEDGE = LATE DETECTION Neuropsychologically Widespread Deficits Neuroanatomically Diffuse LATE STAGE POST 1980 INCREASING INFORMATION = EARLY DETECTION Neuropsychologically Circumscribed Deficits Neuronatomically Focal determined by Large- Scale Network connectivity EARLY STAGE Weintraub & Mesulam, 1993, 1996

DISEASE CLASSIFICATION CLINICAL SYMPTOMS OF DEMENTIA Changes In Cognition, Behavior, Activities of Daily Living RELATED TO REGION OF BRAIN DYSFUNCTION RELATED TO NEUROPATH by probabilities I.E., NEUROANATOMICAL NETWORK Left, Right, Frontal, Parietal, Temporal, Occipital TISSUE DIAGNOSES (%AD, %FTLD, %LBD, %Other) 3 LEVELS OF DEMENTIA CHARACTERIZATION CLINICAL- THE SYMPTOMS THE SYMPTOMS THE PATIENT EXPRESSES AND THE CAREGIVER OBSERVES AS CHANGES; WHAT THE CLINICIAN OBSERVES AND TESTS IN THE OFFICE NEUROANATOMICAL THE LOCATION OF BRAIN DYSFUNCTION REGIONS THAT ARE ATROPHIED (MRI) AND/OR PHYSIOLOGICALLY DYSFUNCTIONAL (PET) NEUROPATHOLOGICAL THE DISEASE THE CELLULAR AND MOLECULAR ABNORMALITIES THE NEUROPATHOLOGIST SEES UNDER THE MICROSCOPE

CLINICAL, NEUROANATOMICAL AND NEUROPATHOLOGICAL RELATIONSHIPS DEMENTIA= What the clinician observes and diagnoses NEUROANATOMY= BRAIN AREA OF dysfunction/ atrophy EARLY NEUROPSYCHOLOGICAL PROFILES Amnesia, Aphasia Visuospatial, Behavior/Personality/Executive DISEASE= What the neuropathologist finds under the microscope % AD Neuropathology %OTHER Neuropathology % FTLD Neuropathology % Lewy Body Neuropathology CLINICAL, NEUROANATOMICAL AND NEUROPATHOLOGICAL RELATIONSHIPS DEMENTIA= What the clinician observes and diagnoses NEUROANATOMY= BRAIN AREA of dysfunction/ atrophy EARLY NEUROPSYCHOLOGICAL PROFILE: APHASIA Primary Progressive Aphasia DISEASE= What the neuropathologist finds under the microscope 30-40% AD Neuropathology 1-2% OTHER CJD, Cortical Lewy Body 60-70% FTLD Neuropathology

CLINICAL, NEUROANATOMICAL AND NEUROPATHOLOGICAL RELATIONSHIPS DEMENTIA= What the clinician observes and diagnoses NEUROANATOMY= BRAIN AREA of dysfunction/ atrophy EARLY NEUROPSYCHOLOGICAL PROFILE: AMNESIA Dementia of the AD type DISEASE= What the neuropathologist finds under the microscope 85% AD Neuropathology 5-10% OTHER Cortical Lewy Body 5-10-% FTLD Neuropathology CLINICAL, NEUROANATOMICAL AND NEUROPATHOLOGICAL RELATIONSHIPS DEMENTIA= What the clinician observes and diagnoses EARLY NEUROPSYCHOLOGICAL PROFILE: Executive/comportmental Beh variant frontotemporal dementia NEUROANATOMY= BRAIN AREA of dysfunction/ atrophy DISEASE= What the neuropathologist finds under the microscope 80% FTLD Neuropathology 20% AD, OTHER

PART 1: What is PPA? PPA is a clinical dementia syndrome caused by neurodegenerative disease. PART 2: How is PPA diagnosed? What are the subtypes of PPA? What tests are used to identify the aphasia profile? PART 3: What are the educational and treatment needs of patients with PPA and their caregivers? What role does the SLP play? What is the Northwestern PPA Program? Neurological examination: Rate of onset, other localizing symptoms; other illness. Etiology-stroke vs neurodegenerative vs tumor vs other? Are there motor or sensory deficits? Neuroimaging (MRI, CT, PET): Rule out other diseases. Evidence of L- sided atrophy or hypometabolic activity? Neuropsychological examination: Evidence of language domain impairment in absence of other cognitive and behavioral deficits? No episodic memory loss; preserved ADL.***** Speech/Language Pathology examination: assess different language modalities: speech, repetition, comprehension, reading, writing; assess different language components: phonology, grammar, semantics; assess functional communication skills for different settings and needs and for planning treatment strategy.

ROOT DIAGNOSIS OF PRIMARY PROGRESSIVE APHASIA Mesulam 2003; Gorno-Tempini et al, 2011 INCLUSIONARY CRITERIA 1. Language deficits emerge slowly and progress and are most prominent feature of the examination: word-finding pauses, paraphasias, agrammatism, comprehension, reading, etc. 2. Aphasia is the identifiable and principal cause of impairment in ADL, otherwise normal. 3. Aphasia is the sole (or most prominent) deficit at onset and for the initial stages of disease. EXCLUSIONARY CRITERIA 1. Diseases other than neurodegeneration can account for the symptoms: stroke, tumor 2. Psychiatric diagnosis accounts for the symptoms 3. Predominant initial episodic memory (visual and verbal), visuospatial/perceptual, and/or executive function deficits occur early in the course 4. Prominent initial behavioral disturbances (e.g., marked disinhibition, emotional detachment, hyperorality, an/or repetitive, compulsive behaviors; personality change) HOW IS PPA DIFFERENT FROM DEMENTIA OF THE AD TYPE AND BEHAVIORAL VARIANT FRONTOTEMPORAL DEMENTIA? COMPARISON OF THREE CLINICAL DEMENTIA DIAGNOSES CLINICAL DEMENTIA DIAGNOSIS MAJOR DOMAIN IMPAIRED Symptoms Dementia of the Alzheimer Type Episodic Memory Forgetfulness, misplacing items, repetitiveness, disorientation Behavioral Variant Frontotemporal Dementia Comportment Executive Function Personality change, lack of judgment and empathy, impulsivity, disinhibition Primary Progressive Aphasia Language Word finding, anomia, speech errors, poor auditory comprehension Gender Females>males Females=Males Females=Males Typical Age at Onset Pathology (Disease) BRAIN REGION 65+ <65 <65 80-90% AD 10% other Medial Temporal Regions 80% FTLD 20% other Frontal Lobes 60-70% FTLD 30-40% AD L PeriSylvian Region

Classification Of Primary Progressive Aphasia and Its Variants Gorno-Tempini, Hillis, Weintraub, et al, Neurology, 2011 Consensus guidelines for unifying classification of PPA and its three variants, Agrammatic (aka PPA-G), Semantic (aka PPA-S) and Logopenic (aka PPA-L) 1. Clearly delimits clinical diagnosis from sources of supporting evidence and etiology (i.e., imaging, neuropathology) 2. Detailed clinical descriptors 3. Supportive Neuroimaging (must fulfill clinical criteria AND have imaging evidence) 4. Supportive Neuropathology (must fulfill clinical criteria AND have post mortem autopsy verification 5. Systematic data collection Caveat: clinical instruments not specified; needs validation CLINICAL DIAGNOSTIC CRITERIA FOR SUBTYPES OF PPA Gorno-Tempini Hillis, Weintraub, et al, Neurology, 2011 PPA-G: NONFLUENT/AGRAMMATIC SUBTYPE PPA-S: SEMANTIC SUBTYPE PPA-L: LOGOPENIC SUBTYPE At least one of the following core features must be present: 1. Agrammatism in language production 2. Effortful, halting speech with inconsistent speech sound errors and distortions (apraxia of speech) At least 2 of 3 of the following other features must be present: 1. Impaired comprehension of syntactically complex sentences 2. Spared single-word comprehension 3. Spared object knowledge Both of the following core features must be present: 1. Impaired confrontation naming 2. Impaired single-word comprehension At least 3 of the following other diagnostic features must be present: 1. Impaired object knowledge, particularly for low frequency or low-familiarity items 2. Surface dyslexia or dysgraphia 3. Spared repetition 4. Spared speech production (grammar and motor Speech) Both of the following core features must be present: 1. Impaired single-word retrieval in spontaneous speech and naming 2. Impaired repetition of sentences and phrases At least 3 of the following other features must be present: 1. Speech (phonologic) errors in spontaneous speech and naming 2. Spared single-word comprehension and object knowledge 3. Spared motor speech 4. Absence of frank agrammatism

NEUROPSYCHOLOGY OF PPA NEUROPSYCHOLOGY OF PPA (An Aphasic Dementia ) ORDER OF SEVERITY OF IMPAIRMENTS BY DOMAIN Verbal Skills Delayed Recall* Cognitive Flexibility and Abstraction* Memory Acquisition* Attention/Concentration* Performance Skill (non verbal, largely) mostly due to the fact that measures of these functions Zakzanis, 1999: The Neuropsychological Signature of Primary are verbal Progressive Aphasia, Brain and Language

TEST STRATEGIES: How can you tell if someone with aphasia can remember things, or reason, or understand most non language test instructions? CHALLENGES FOR TESTING NON LANGUAGE DOMAINS Tests Contain Complex Verbal Instructions: Block Designs, WCST, Picture Completion Tests Contain Verbal Stimuli: Word lists, stories, MMSE, Trail Making B Tests Require Spoken Output: WAIS Similarities, Arithmetic, RAVLT, story recall, etc. Try to select tests that eliminate complex language THREE WORDS THREE SHAPES EPISODIC MEMORY TEST (3W3S) Mesulam & Weintraub, 1985, 2000; Weintraub et al, 2000 CONDITION PRIDE HUNGE R LEARNING/MEMORY COMPONENT TESTED STATION COPY INCIDENTAL RECALL ACQUISITION TRIALS DELAYED RECALL Assures attention to stimuli, verifies writing and drawing ability impact on performance How much is remembered without forewarning,i.e., effortlessly? Re-expose stimuli on two learning trials (30 secs each) followed by immediate reproduction to assure encoding, reach a level of criterion Retrieval/retention over time MULTIPLE CHOICE Recognition memory

Verbal and Nonverbal Memory In Primary Progressive Aphasia: The Three Words-Three Shapes Test Weintraub et al, Beh Neurol, 2013 Dementia of the AD Type (DAT) patient Stimuli Copy Primary Progressive Aphasia (PPA) patient (form 2) Amnesia in DAT interferes with effortless encoding of shapes and delayed recall of words and shapes and all recognition is abnormal Effortless Encoding Effortful Encoding/ Acquisition Aphasia in PPA interferes with effortless encoding and delayed retrieval of words but not shapes and all recognition is normal Delayed Recall Visual-Verbal Test (Feldman & Drasgow, 1959) 1 2 3 4 SORT 1 1 2 3 4 SHIFT SORT 2 1 2 3 4

S H I F T S 10 10 5 5 Wicklund, Johnson, Weintraub, 2004 0 0 NC ONC PPA PPA PRAD FTD * S O R T S 20 20 10 10 0 0 NC ONC PPA PPA PRAD FTD * APHASIA ASSESSMENT IN PPA Western Aphasia Battery (WAB-R) APHASIA QUOTIENT Composite Score= Mild, Moderate, Severe Object/Color/Letter/Number/ Shape Comprehension Object/Color/Letter/Number/ Shape Naming Complex Commands Spontaneous Speech (Fluency, Content) Reading, Writing

APHASIA ASSESSMENT IN PPA Boston Diagnostic Aphasia Examination (BDAE) Boston Naming Test (BNT) Northwestern Naming Battery (NNB) Northwestern Anagram Test (NAT) https://flintbox.com/public/project/19927/ Northwestern Assessment of Verbs and Sentences (NAVS) http://flintbox.com/public/project/9299/ Psycholinguistic Assessment of Aphasia (PALPA) Multilingual Naming Test (MINT; Gollan et al, 2012, 2013) APHASIA ASSESSMENT IN PPA LANGUAGE COMPONENTS PHONOLOGY Sound Discrimination, Production SEMANTICS Single Word Comprehension, Naming GRAMMAR (SYNTAX, MORPHOLOGY) Production, Comprehension

1. Fluent Non Fluent Distinction Oversimplifies - PPA patients can be at least intermittently nonfluent even though they do not have impairments in producing syntactically correct sentences 2. Such a dissociation is key for distinguishing the agrammatic from the logopenic subtype of PPA 3. PPA with agrammatism predicts tauopathy

Dissociations Between Fluency And Agrammatism In Primary Progressive Aphasia Thompson CK, Cho S, Hsu CJ, Wieneke C, Rademaker A, Weitner BB, Mesulam M-M, Weintraub S Aphasiology, 2012 Dissociations Between Fluency And Agrammatism In Primary Progressive Aphasia Thompson CK, Cho S, Hsu CJ, Wieneke C, Rademaker A, Weitner BB, Mesulam M-M, Weintraub S Aphasiology, 2012 FLUENCY DEFICITS IN PPA-G AND PPA-L GRAMMATICAL DEFICITS IN PPA-G, BUT NOT PPA-L =PPA-G; =PPA-L; =PPA-S

Dissociations Between Fluency And Agrammatism In Primary Progressive Aphasia Thompson CK, Cho S, Hsu CJ, Wieneke C, Rademaker A, Weitner BB, Mesulam M-M, Weintraub S Aphasiology, 2012 MORPHOLOGICAL DEFICITS IN PPA-G BUT NOT PPA-L =PPA-G; =PPA-L; =PPA-S DISSOCIATION OF FLUENCY FROM GRAMMAR IN THE FRONTAL LOBES: NAT VS MLU MFG IFS IFGp IFGa Courtesy Emily Rogalski, PhD,

1. Different regions of brain atrophy are associated with reduced fluency and reduced grammatical processing in PPA 2. Impairments of fluency and grammar do not always go together in PPA Challenges For Testing Grammar Production 1. If speech production is decreased, it is difficult to know if output is grammatically correct or not 2. Need for a test of grammatical processing that: - eliminates speech production - reduces working memory load - reduces impact of word finding deficits

NORTHWESTERN ANAGRAM TEST (NAT) Weintraub, Mesulam, Thompson girl boy tickle the girl tickling the is boy the girl is tickling the boy Demographics and Test scores for PPA patients and controls WAB AQ = Western Aphasia Battery Aphasia Quotient NAT-10 = Northwestern Anagram Test, 10-item version

Weintraub et al, 2009

MesulamM et al. Brain 2012;135:1537-1553 PPA Subtyping Algorithm For Mild and Moderate Stage PPA 1. Single Word Comprehension- PPVT IV 2. Grammar- Northwestern Anagram Test (NAT), Northwestern Assessment of Verbs and Sentences (NAVS) Sentence Production Priming Test (SPPT) 3. WAB Repetition- 6 Complex Phrases 4. Naming- Boston Naming Test Mesulam, Wienecke, Thompson, Rogalski, Weintraub Brain, 2012

PART 1: What is PPA? PPA is a clinical dementia syndrome caused by neurodegenerative disease. PART 2: How is PPA diagnosed? What are the subtypes of PPA? What tests are used to identify the aphasia profile? PART 3: What are the educational and treatment needs of patients with PPA and their caregivers? What role does the SLP play? What is the Northwestern PPA Program? LEVEL OF IMPAIRMENT MEASURED BY THE ADLQ 70 SEV 60 PERCENT IMPAIRMENT 50 40 30 20 10 MOD MILD AD FTD PPA 0 1 2 3 4 5 6 7

ROLE OF THE SPEECH-LANGUAGE PATHOLOGIST IN WORKING WITH PATIENTS WITH PPA VERY DIFFERENT FROM THE STROKE OR TBI MODEL Patients recover from stroke: treatment aims to restore function Patients get worse with PPA: treatment must change with the course of illness Strategies must aim for compensation rather than restoration; since patients retain many cognitive abilities while language is declining, these can be capitalized on for compensatory strategies Strategies need to focus on improving communication rather than language Involvement of caregivers from the beginning to focus on the communication dyad and anticipate changes over time Use of later stage strategies from the beginning that will not be discarded when disease progresses e.g., augmentative communication device may be too hard to use after initial stages Primary Progressive Aphasia Clinical Evaluation Program @ Northwestern: Neurology Neuropsychology Speech-Language Pathology Social Work Language in Primary Progressive Aphasia Research Program @ Northwestern: Neuropsychological Evaluation MRI Scans Electrophysiological Studies Neuropathology/Genetics Studies

PPA RESOURCES AT THE NORTHWESTERN For Patients/Families Information about PPA (in multiple languages) Support Groups Research Programs Links to resources (e.g., NAA, AFTD, Other) For Researchers/Clinicians Detailed diagnostic criteria (including video) Add resources/studies Add subjects for collaboration DISTRIBUTION OF PARTICIPANTS ACROSS THE UNITED STATES IN THE NORTHWESTERN PPA RESEARCH PROGRAM

www.ppaconnection.org Clinicians may view video case samples of PPA subtypes on this website but must first register